[
    "{\"step_by_step_thinking\": \"To determine if capmatinib is effective for glioblastoma, we need to review the available evidence. Glioblastoma is a type of brain cancer that is known to be aggressive and difficult to treat. Capmatinib is a targeted therapy that inhibits the MET receptor tyrosine kinase. To answer this question, we need to look for clinical trials or studies that have specifically evaluated the use of capmatinib in patients with glioblastoma. We should consider the results of these studies to determine if capmatinib has shown any efficacy in treating glioblastoma.\", \"answer_choice\": \"B. no\"}"
]